Income Statement Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:30:59 12/03/2026 GMT			5-day change	1st Jan Change
120.84 ^CHF	-0.33%		-3.19%	+10.26%

03:11pm	Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research	RE
10:23am	Mesoblast Limited Appoints Dr. Teresa Montagut As Head Of Clinical Development And Medical Affairs	CI

8b5be83.JofGGDumH8qWg9d7pV7qKt8fjcslMR-6LIVXgoxnirg.Fc-DT1mVfbPRz7Iw4weof7xY2f92aXrCAfIO7sg0wpVNsfJec9Bup_7xmg

Published financial data: NOVARTIS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	51.63B	50.54B	45.44B	50.32B	54.53B
Other Revenues, Total	1.25B	1.28B	1.22B	1.4B	2.14B
Total Revenues	52.88B	51.83B	46.66B	51.72B	56.67B
Cost of Goods Sold, Total	15.44B	15.08B	12.02B	12.82B	13.62B
Gross Profit	37.44B	36.74B	34.64B	38.91B	43.05B
Selling General & Admin Expenses, Total	14.82B	14.19B	12.49B	12.56B	13.24B
R&D Expenses	9.15B	9.25B	9.01B	9.51B	10.69B
Other Operating Expenses	653M	449M	498M	512M	124M
Other Operating Expenses, Total	24.62B	23.88B	22B	22.59B	24.05B
Operating Income	12.82B	12.86B	12.64B	16.32B	19B
Interest Expense, Total	-811M	-837M	-855M	-1.01B	-1.14B
Interest And Investment Income	71M	379M	627M	568M	373M
Net Interest Expenses	-740M	-458M	-228M	-438M	-771M
Income (Loss) On Equity Invest.	15.34B	-9M	-13M	-38M	-12M
Currency Exchange Gains (Loss)	-69M	-184M	-214M	-258M	-300M
Other Non Operating Income (Expenses)	-153M	-54M	3M	61M	-104M
EBT, Excl. Unusual Items	27.2B	12.15B	12.19B	15.65B	17.82B
Restructuring Charges	-	-	-951M	-364M	-478M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	38M	-260M	-105M	-45M	48M
Gain (Loss) On Sale Of Assets	728M	166M	225M	45M	50M
Asset Writedown	-653M	-1.69B	-3.09B	-1.43B	-552M
Legal Settlements	-212M	-369M	542M	-89M	-161M
Other Unusual Items	-965M	-1.63B	310M	-126M	-373M
EBT, Incl. Unusual Items	26.14B	8.37B	9.12B	13.64B	16.35B
Income Tax Expense	2.12B	1.42B	551M	1.7B	2.38B
Earnings From Continuing Operations	24.02B	6.96B	8.57B	11.94B	13.97B
Earnings Of Discontinued Operations	-	-	6.28B	-	-
Net Income to Company	24.02B	6.96B	14.85B	11.94B	13.97B
Minority Interest	3M	-	-4M	2M	17M
Net Income - (IS)	24.02B	6.96B	14.85B	11.94B	13.98B
Net Income to Common Incl Extra Items	24.02B	6.96B	14.85B	11.94B	13.98B
Net Income to Common Excl. Extra Items	24.02B	6.96B	8.57B	11.94B	13.98B
Per Share Items
Net EPS - Basic	10.71	3.19	7.15	5.92	7.21
Basic EPS - Continuing Operations	10.71	3.19	4.13	5.92	7.21
Basic Weighted Average Shares Outstanding	2.24B	2.18B	2.08B	2.02B	1.94B
Net EPS - Diluted	10.63	3.17	7.1	5.87	7.15
Diluted EPS - Continuing Operations	10.63	3.17	4.1	5.87	7.15
Diluted Weighted Average Shares Outstanding	2.26B	2.2B	2.09B	2.04B	1.96B
Normalized Basic EPS	7.58	3.48	3.67	4.85	5.75
Normalized Diluted EPS	7.52	3.46	3.64	4.81	5.7
Dividend Per Share	3.39	3.46	3.92	3.86	4.67
Payout Ratio	30.67	107.92	48.86	63.85	55.91
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	17.94B	18B	17.52B	20.66B	23.47B
EBITA	16.73B	16.84B	16.6B	19.78B	22.52B
EBIT	12.82B	12.86B	12.64B	16.32B	19B
EBITDAR	17.95B	18.01B	17.53B	20.67B	23.48B
Effective Tax Rate - (Ratio)	8.11	16.92	6.04	12.47	14.59
Current Domestic Taxes	958M	617M	1.14B	897M	1.4B
Current Foreign Taxes	1.47B	1.45B	1.29B	1.49B	1.35B
Total Current Taxes	2.43B	2.07B	2.43B	2.38B	2.74B
Deferred Domestic Taxes	-23M	142M	-355M	245M	1.15B
Deferred Foreign Taxes	-286M	-797M	-1.52B	-927M	-1.51B
Total Deferred Taxes	-309M	-655M	-1.88B	-682M	-360M
Normalized Net Income	17B	7.6B	7.61B	9.78B	11.15B
Interest Capitalized	4M	5M	3M	5M	8M
Interest on Long-Term Debt	62M	60M	62M	72M	76M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	9.54B	10B	11.37B	10.02B	11.2B
Net Rental Expense, Total	13M	9M	11M	12M	7M
Imputed Operating Lease Interest Expense	2.45M	2.05M	2.78M	3.36M	1.93M
Imputed Operating Lease Depreciation	10.55M	6.95M	8.22M	8.64M	5.07M
Stock-Based Comp., Other (Total)	979M	1.05B	1.14B	1.31B	1.33B
Total Stock-Based Compensation	979M	1.05B	1.14B	1.31B	1.33B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	12.41B	7.52B	13.39B	11.46B	11.44B
Short Term Investments	15.82B	11.21B	680M	1.89B	98M
Total Cash And Short Term Investments	28.22B	18.73B	14.07B	13.35B	11.53B
Accounts Receivable, Total	8B	8.07B	7.11B	7.42B	8.94B
Other Receivables	1.56B	1.74B	2.14B	1.94B	1.9B
Total Receivables	9.56B	9.8B	9.25B	9.36B	10.83B
Inventory	6.67B	7.18B	5.91B	5.72B	6.27B
Prepaid Expenses	1.1B	911M	764M	985M	1.15B
Other Current Assets, Total	163M	297M	484M	283M	672M
Total Current Assets	45.72B	36.91B	30.48B	29.7B	30.46B
Gross Property Plant And Equipment	28.71B	26.3B	22.8B	21.97B	25.08B
Accumulated Depreciation	-15.6B	-14.11B	-11.88B	-11.1B	-12.73B
Net Property Plant And Equipment	13.11B	12.2B	10.92B	10.87B	12.35B
Long-term Investments	2.27B	1.61B	1.83B	1.13B	1.09B
Goodwill	29.6B	29.3B	23.34B	24.76B	25.57B
Other Intangibles, Total	28.68B	27.22B	26.88B	26.92B	29.41B
Accounts Receivable Long-Term	70M	59M	104M	54M	52M
Loans Receivable Long-Term	78M	85M	114M	102M	142M
Deferred Tax Assets Long-Term	3.74B	3.74B	4.31B	4.36B	5.44B
Deferred Charges Long-Term	5.5B	4.42B	-	-	-
Other Long-Term Assets, Total	3.04B	1.91B	1.97B	4.36B	6.44B
Total Assets	132B	117B	99.94B	102B	111B
Liabilities
Accounts Payable, Total	5.55B	5.15B	4.93B	4.57B	4.46B
Accrued Expenses, Total	5.15B	5.39B	5.17B	5.25B	5.36B
Short-term Borrowings	3.61B	3.64B	3.89B	4.73B	4.73B
Current Portion of Long-Term Debt	2.69B	2.3B	2.28B	3.5B	875M
Current Portion of Leases	275M	251M	230M	235M	263M
Current Income Taxes Payable	2.42B	2.53B	1.89B	1.6B	1.97B
Unearned Revenue Current, Total	123M	123M	98M	127M	-
Other Current Liabilities	10.4B	9.28B	7.89B	8.68B	9.63B
Total Current Liabilities	30.21B	28.66B	26.39B	28.69B	27.28B
Long-Term Debt	22.9B	20.24B	18.44B	21.37B	27.94B
Long-Term Leases	1.62B	1.54B	1.6B	1.57B	1.66B
Pension & Other Post Retirement Benefits	3.79B	2.64B	2.73B	2.47B	2.56B
Deferred Tax Liability Non Current	3.07B	2.69B	2.25B	2.42B	3.4B
Other Non Current Liabilities	2.38B	2.27B	1.79B	1.6B	1.57B
Total Liabilities	63.97B	58.03B	53.2B	58.12B	64.4B
Common Stock, Total	901M	890M	825M	793M	766M
Retained Earnings	70.99B	63.54B	49.65B	46.56B	44.72B
Treasury Stock	-48M	-92M	-41M	-53M	-50M
Comprehensive Income and Other	-4.19B	-5B	-3.77B	-3.26B	694M
Total Common Equity	67.66B	59.34B	46.67B	44.05B	46.13B
Minority Interest	167M	81M	83M	80M	419M
Total Equity	67.82B	59.42B	46.75B	44.13B	46.55B
Total Liabilities And Equity	132B	117B	99.94B	102B	111B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.23B	2.12B	2.04B	1.98B	1.91B
ECS Total Common Shares Outstanding	2.23B	2.12B	2.04B	1.98B	1.91B
Book Value / Share	30.27	28	22.83	22.3	24.18
Tangible Book Value	9.38B	2.82B	-3.55B	-7.62B	-8.85B
Tangible Book Value Per Share	4.2	1.33	-1.74	-3.86	-4.64
Total Debt	31.09B	27.96B	26.44B	31.4B	35.46B
Net Debt	2.87B	9.24B	12.37B	18.05B	23.92B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.16B	-1.41B	-897M	-1.09B	-2.65B
Debt Equivalent Oper. Leases	104M	72M	88M	96M	56M
Minority Interest, Total (Incl. Fin. Div)	167M	81M	83M	80M	419M
Equity Method Investments, Total	205M	143M	205M	119M	98M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	870M	934M	963M	843M	975M
Inventories - Work In Process, Total	3.16B	3.67B	3.5B	3.45B	3.96B
Inventories - Finished Goods, Total	2.64B	2.57B	1.45B	1.43B	1.33B
Land - (BS)	492M	451M	403M	376M	446M
Buildings, Total	11.82B	11.4B	10.15B	9.53B	10.75B
Machinery, Total	13.33B	11.84B	9.63B	9.05B	10.45B
Full Time Employees	104K	102K	76.06K	75.88K	75.27K
Accumulated Allowance for Doubtful Accounts (Supple)	83M	62M	51M	58M	52M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	24.02B	6.96B	14.85B	11.94B	13.98B
Depreciation & Amortization - CF	1.53B	1.47B	1.18B	1.14B	1.23B
Amortization of Goodwill and Intangible Assets - (CF)	3.9B	3.98B	3.96B	3.46B	3.52B
Depreciation & Amortization, Total	5.43B	5.45B	5.14B	4.6B	4.74B
(Gain) Loss From Sale Of Asset	-677M	-333M	-180M	-74M	116M
(Gain) Loss on Sale of Investments - (CF)	-38M	260M	106M	45M	-50M
Asset Writedown & Restructuring Costs	684M	1.73B	3.14B	1.47B	581M
(Income) Loss On Equity Investments - (CF)	-15.34B	9M	15M	38M	12M
Stock-Based Compensation (CF)	736M	823M	865M	1.04B	1.1B
Net Cash From Discontinued Operations	-	-	238M	-	-
Other Operating Activities, Total	1.13B	1.23B	-7.81B	369M	1.72B
Change In Accounts Receivable	-389M	-589M	-1.5B	-931M	-1.12B
Change In Inventories	81M	-830M	-546M	-225M	34M
Change In Accounts Payable	-21M	-48M	479M	-105M	-273M
Change in Other Net Operating Assets	-549M	-421M	-332M	-552M	-1.7B
Cash from Operations	15.07B	14.24B	14.46B	17.62B	19.14B
Capital Expenditure	-1.38B	-1.2B	-1.06B	-1.37B	-1.55B
Sale of Property, Plant, and Equipment	240M	167M	237M	86M	13M
Cash Acquisitions	-633M	-864M	-3.56B	-4.02B	-2.92B
Divestitures	66M	-15M	3M	107M	-88M
Sale (Purchase) of Intangible assets	-845M	-1.27B	262M	-2.37B	-2.19B
Investment in Marketable and Equity Securities, Total	6.82B	4.65B	10.84B	43M	1.87B
Other Investing Activities, Total	-57M	-1M	-1.12B	3M	-24M
Cash from Investing	4.21B	1.47B	5.6B	-7.51B	-4.88B
Short Term Debt Issued, Total	-	295M	546M	958M	5M
Long-Term Debt Issued, Total	16M	16M	-	6.14B	6.1B
Total Debt Issued	16M	311M	546M	7.1B	6.1B
Short Term Debt Repaid, Total	-3.52B	-	-	-289M	-
Long-Term Debt Repaid, Total	-2.48B	-2.87B	-2.48B	-2.42B	-3.67B
Total Debt Repaid	-6B	-2.87B	-2.48B	-2.71B	-3.67B
Issuance of Common Stock	53M	100M	153M	30M	27M
Repurchase of Common Stock	-3.06B	-10.65B	-8.72B	-8.33B	-9.21B
Common Dividends Paid	-7.37B	-7.51B	-7.26B	-7.62B	-7.82B
Common & Preferred Stock Dividends Paid	-7.37B	-7.51B	-7.26B	-7.62B	-7.82B
Other Financing Activities, Total	94M	55M	3.48B	-207M	-294M
Cash from Financing	-16.26B	-20.56B	-14.28B	-11.74B	-14.87B
Foreign Exchange Rate Adjustments	-266M	-32M	100M	-298M	576M
Net Change in Cash	2.75B	-4.89B	5.88B	-1.93B	-24M
Supplemental Items
Cash Interest Paid	664M	696M	751M	855M	981M
Cash Income Tax Paid (Refund)	2.34B	1.98B	2.79B	2.26B	2.56B
Levered Free Cash Flow	13.12B	9.69B	12.13B	12.04B	12.12B
Unlevered Free Cash Flow	13.62B	10.21B	12.67B	12.67B	12.83B
Change In Net Working Capital	-1.42B	1.85B	713M	-295M	1.39B
Net Debt Issued / Repaid	-5.99B	-2.56B	-1.94B	4.39B	2.43B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.18	6.45	7.27	10.09	11.14
Return on Total Capital	8.28	8.63	9.84	13.72	15.08
Return On Equity %	38.59	10.93	16.15	26.28	30.81
Return on Common Equity	38.66	10.95	16.16	26.33	31.01
Margin Analysis
Gross Profit Margin %	70.81	70.9	74.24	75.22	75.97
SG&A Margin	28.02	27.38	26.77	24.29	23.36
EBITDA Margin %	33.92	34.74	37.54	39.95	41.42
EBITA Margin %	31.63	32.49	35.58	38.24	39.74
EBIT Margin %	24.25	24.81	27.09	31.55	33.53
Income From Continuing Operations Margin %	45.42	13.42	18.37	23.08	24.64
Net Income Margin %	45.43	13.42	31.83	23.09	24.67
Net Avail. For Common Margin %	45.43	13.42	18.36	23.09	24.67
Normalized Net Income Margin	32.16	14.66	16.32	18.91	19.68
Levered Free Cash Flow Margin	24.81	18.69	26	23.27	21.38
Unlevered Free Cash Flow Margin	25.77	19.7	27.15	24.49	22.64
Asset Turnover
Asset Turnover	0.41	0.42	0.43	0.51	0.53
Fixed Assets Turnover	3.91	4.1	4.04	4.75	4.88
Receivables Turnover (Average Receivables)	6.36	6.29	5.99	6.93	6.67
Inventory Turnover (Average Inventory)	2.24	2.18	1.84	2.2	2.27
Short Term Liquidity
Current Ratio	1.51	1.29	1.16	1.04	1.12
Quick Ratio	1.25	1	0.88	0.79	0.82
Operating Cash Flow to Current Liabilities	0.5	0.5	0.55	0.61	0.7
Days Sales Outstanding (Average Receivables)	57.35	58.03	60.94	52.84	54.75
Days Outstanding Inventory (Average Inventory)	163.13	167.46	198.72	166.16	160.69
Average Days Payable Outstanding	133.56	125.22	170.86	137.67	116.31
Cash Conversion Cycle (Average Days)	86.91	100.27	88.79	81.33	99.13
Long Term Solvency
Total Debt/Equity	45.84	47.06	56.55	71.16	76.17
Total Debt / Total Capital	31.43	32	36.12	41.58	43.24
LT Debt/Equity	36.16	36.66	42.85	51.97	63.57
Long-Term Debt / Total Capital	24.79	24.93	27.37	30.37	36.09
Total Liabilities / Total Assets	48.54	49.41	53.22	56.84	58.04
EBIT / Interest Expense	15.81	15.36	14.79	16.22	16.61
EBITDA / Interest Expense	22.51	21.87	20.79	20.79	20.76
(EBITDA - Capex) / Interest Expense	20.81	20.44	19.55	19.44	19.41
Total Debt / EBITDA	1.7	1.53	1.49	1.5	1.49
Net Debt / EBITDA	0.16	0.5	0.7	0.86	1.01
Total Debt / (EBITDA - Capex)	1.84	1.63	1.58	1.61	1.6
Net Debt / (EBITDA - Capex)	0.17	0.54	0.74	0.92	1.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.97	-1.98	7.36	10.85	9.57
Gross Profit, 1 Yr. Growth %	5.48	-1.86	7.7	12.32	10.66
EBITDA, 1 Yr. Growth %	5.71	0.38	9.93	17.95	13.6
EBITA, 1 Yr. Growth %	6.89	0.68	10.91	19.12	13.88
EBIT, 1 Yr. Growth %	5.23	0.27	12.78	29.09	16.45
Earnings From Cont. Operations, 1 Yr. Growth %	197.58	-71.04	41.71	39.28	16.99
Net Income, 1 Yr. Growth %	197.58	-71.05	113.52	-19.59	17.11
Normalized Net Income, 1 Yr. Growth %	128.24	-55.51	15.19	28.45	14.03
Diluted EPS Before Extra, 1 Yr. Growth %	201.99	-70.18	48.55	43.17	21.81
Accounts Receivable, 1 Yr. Growth %	-2.58	0.76	-11.89	4.45	20.4
Inventory, 1 Yr. Growth %	-6.52	7.64	-17.59	-3.21	9.54
Net Property, Plant and Equip., 1 Yr. Growth %	-5.98	-6.95	-10.42	-0.47	13.6
Total Assets, 1 Yr. Growth %	3.14	-10.88	-14.91	2.3	8.51
Tangible Book Value, 1 Yr. Growth %	-270.18	-69.95	121.65	114.61	16.04
Common Equity, 1 Yr. Growth %	19.54	-12.29	-21.36	-5.62	4.73
Cash From Operations, 1 Yr. Growth %	10.41	-5.54	1.56	21.86	8.66
Capital Expenditures, 1 Yr. Growth %	8.08	-13.06	15.72	28.87	13.32
Levered Free Cash Flow, 1 Yr. Growth %	2.26	-26.16	41.76	-0.78	0.64
Unlevered Free Cash Flow, 1 Yr. Growth %	1.89	-25.07	39.84	-0	1.29
Dividend Per Share, 1 Yr. Growth %	-0.02	1.77	13.24	-1.44	20.81
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.22	1.92	3.01	9.09	10.21
Gross Profit, 2 Yr. CAGR %	4.55	2.79	3.11	10.47	12.22
EBITDA, 2 Yr. CAGR %	16.27	9.81	5.86	21.75	13.7
EBITA, 2 Yr. CAGR %	18.45	11.22	6.53	23.47	14.29
EBIT, 2 Yr. CAGR %	18.8	12.55	7.38	33.09	36.27
Earnings From Cont. Operations, 2 Yr. CAGR %	83.32	-7.17	-38.82	40.49	27.65
Net Income, 2 Yr. CAGR %	43.09	-7.18	-21.37	31.03	-2.96
Normalized Net Income, 2 Yr. CAGR %	74.52	10.91	-30.86	35.05	35.11
Diluted EPS Before Extra, 2 Yr. CAGR %	85.78	-5.1	-36.41	45.84	32.06
Accounts Receivable, 2 Yr. CAGR %	-1.8	-0.92	-5.78	-4.07	12.14
Inventory, 2 Yr. CAGR %	5.56	0.31	-5.82	-10.69	2.97
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.36	-6.46	-8.7	-5.58	6.34
Total Assets, 2 Yr. CAGR %	5.52	-4.13	-12.92	-6.7	5.36
Tangible Book Value, 2 Yr. CAGR %	29.55	-28.49	-38.44	118.1	57.81
Common Equity, 2 Yr. CAGR %	10.43	2.4	-16.95	-13.85	-0.58
Cash From Operations, 2 Yr. CAGR %	5.17	2.12	-2.05	11.25	15.07
Capital Expenditures, 2 Yr. CAGR %	-0.04	-3.07	-0.28	22.12	20.85
Levered Free Cash Flow, 2 Yr. CAGR %	4.37	-8.45	1.51	28.32	-5.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.09	-8.14	1.62	27.34	-4.98
Dividend Per Share, 2 Yr. CAGR %	4.24	1.03	7.35	5.64	9.12
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.68	2.11	-2.21	5.56	9.25
Gross Profit, 3 Yr. CAGR %	5.83	2.37	-0.13	6.09	10.54
EBITDA, 3 Yr. CAGR %	8.26	10.71	5.47	9.74	18.97
EBITA, 3 Yr. CAGR %	10.64	12.2	6.84	10.58	20.19
EBIT, 3 Yr. CAGR %	12.85	12.27	7.59	14.18	27.3
Earnings From Cont. Operations, 3 Yr. CAGR %	23.34	-0.9	2.03	-19.52	32.17
Net Income, 3 Yr. CAGR %	23.96	-15.99	22.53	-20.78	26.22
Normalized Net Income, 3 Yr. CAGR %	23.02	10.81	7.24	-15.01	27.64
Diluted EPS Before Extra, 3 Yr. CAGR %	24.87	0.96	5.22	-16.66	37.34
Accounts Receivable, 3 Yr. CAGR %	-2.84	-0.95	-4.72	-2.48	3.48
Inventory, 3 Yr. CAGR %	-1.41	6.25	-6.05	-4.96	-4.4
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.83	-3.91	-7.8	-6.04	0.43
Total Assets, 3 Yr. CAGR %	-3.26	-0.26	-7.86	-8.11	-1.88
Tangible Book Value, 3 Yr. CAGR %	-21.85	-20.4	-13.61	-6.66	76.73
Common Equity, 3 Yr. CAGR %	-4.88	2.27	-6.23	-13.33	-8.05
Cash From Operations, 3 Yr. CAGR %	1.83	1.47	1.94	5.34	10.38
Capital Expenditures, 3 Yr. CAGR %	3.19	-4.58	-5.97	8.62	19.11
Levered Free Cash Flow, 3 Yr. CAGR %	8.9	-7	1.63	0.74	18.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.25	-6.71	1.54	1.08	17.99
Dividend Per Share, 3 Yr. CAGR %	6.08	3.51	4.94	4.34	10.48
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.38	3.61	0.24	1.22	2.58
Gross Profit, 5 Yr. CAGR %	3.16	4.15	1.86	2.58	4.36
EBITDA, 5 Yr. CAGR %	4.43	6.94	4.38	9.26	9.47
EBITA, 5 Yr. CAGR %	5.26	7.8	6.09	10.65	10.59
EBIT, 5 Yr. CAGR %	7.13	7.53	7.21	12.43	13.36
Earnings From Cont. Operations, 5 Yr. CAGR %	29.1	-1.49	-7.71	10.81	11.59
Net Income, 5 Yr. CAGR %	29.05	-2.02	3.32	0.35	11.62
Normalized Net Income, 5 Yr. CAGR %	24.74	5.4	-3.57	11.87	12.55
Diluted EPS Before Extra, 5 Yr. CAGR %	30.58	0	-5.57	13.77	15.23
Accounts Receivable, 5 Yr. CAGR %	-0.49	-1.27	-4.02	-2.21	1.69
Inventory, 5 Yr. CAGR %	1.28	0.88	-3.2	-0.88	-2.54
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.47	-5.83	-6.99	-4.58	-2.39
Total Assets, 5 Yr. CAGR %	0.26	-2.47	-7.24	-2.89	-2.78
Tangible Book Value, 5 Yr. CAGR %	-10.98	-30.76	-28.97	6.42	9.94
Common Equity, 5 Yr. CAGR %	-2	-4.36	-9.9	-4.51	-4.01
Cash From Operations, 5 Yr. CAGR %	5.6	2.44	0.26	5.28	7
Capital Expenditures, 5 Yr. CAGR %	-5.84	-2	-3.31	-0.19	3.96
Levered Free Cash Flow, 5 Yr. CAGR %	11.08	2.25	3.62	-0.01	0.95
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.69	2.25	3.36	0.15	1.18
Dividend Per Share, 5 Yr. CAGR %	4.5	3.31	6.65	4.36	6.59